VC-backed Verve Therapeutics hires chief scientific officer
Cambridge, Massachusetts-based Verve Therapeutics, a next-generation cardiovascular company, has named Dr. Andrew Bellinger as chief scientific officer. Dr. Bellinger is a general cardiologist at Brigham and Women’s Hospital. Verve’s backers include GV, ARCH Venture Partners, F-Prime Capital and Biomatics Capital.
3 October 2019•3 mins read
